Oxidative stress: a key modulator in neurodegenerative diseases

A Singh, R Kukreti, L Saso, S Kukreti - Molecules, 2019 - mdpi.com
Oxidative stress is proposed as a regulatory element in ageing and various neurological
disorders. The excess of oxidants causes a reduction of antioxidants, which in turn produce …

[HTML][HTML] EGF receptor ligands: recent advances

B Singh, G Carpenter, RJ Coffey - F1000Research, 2016 - ncbi.nlm.nih.gov
Seven ligands bind to and activate the mammalian epidermal growth factor (EGF) receptor
(EGFR/ERBB1/HER1): EGF, transforming growth factor-alpha (TGFA), heparin-binding EGF …

Herbal medicine: biomolecular and clinical aspects

IFF Benzie, S Wachtel-Galor - 2011 - books.google.com
Responding to the increased popularity of herbal medicines and other forms of
complementary or alternative medicine world-wide, this reference reviews and evaluates …

Cellular proteostasis in neurodegeneration

A Kurtishi, B Rosen, KS Patil, GW Alves… - Molecular neurobiology, 2019 - Springer
The term proteostasis reflects the fine-tuned balance of cellular protein levels, mediated
through a vast network of biochemical pathways. This requires the regulated control of …

The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease

S Habtemariam - Evidence‐based Complementary and …, 2016 - Wiley Online Library
Rosemary (Rosmarinus officinalis L.) is one of the most economically important species of
the family Lamiaceae. Native to the Mediterranean region, the plant is now widely distributed …

Curcumin and Alzheimer's disease

T Hamaguchi, K Ono, M Yamada - CNS neuroscience & …, 2010 - Wiley Online Library
Curcumin has a long history of use as a traditional remedy and food in Asia. Many studies
have reported that curcumin has various beneficial properties, such as antioxidant …

Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway

T Hamaguchi, K Ono, A Murase, M Yamada - The American journal of …, 2009 - Elsevier
Inhibition of amyloid-β (Aβ) aggregation is an attractive therapeutic strategy for Alzheimer's
disease (AD). Certain phenolic compounds have been reported to have anti-Aβ aggregation …

Polyphenols as potential metal chelation compounds against Alzheimer's disease

J Lakey-Beitia, AM Burillo, G La Penna… - Journal of …, 2021 - content.iospress.com
Alzheimer's disease (AD) is the most common neurodegenerative disease affecting more
than 50 million people worldwide. The pathology of this multifactorial disease is primarily …

Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model

N Uabundit, J Wattanathorn, S Mucimapura… - Journal of …, 2010 - Elsevier
ETHNOPHARMACOLOGICAL RELEVANCE: Bacopa monnieri (L.) Wettst., a plant
belonging to the family Scrophulariaceae, has been used in the traditional system of …

Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells

K Jiménez-Aliaga, P Bermejo-Bescós, J Benedí… - Life sciences, 2011 - Elsevier
AIMS: Quercetin and rutin have been reported to exert numerous pharmacological activities,
such as free-radical scavenging, effects on immune and inflammatory cell functions, and …